Lubiprostone increases small intestinal smooth muscle contractions through a prostaglandin E receptor 1 (EP1)-mediated pathway

Journal of Neurogastroenterology and Motility

Volumn 19, Issue 3, 2013, Pages 312-318

  Chan, Walter W ^a,b   Mashimo, Hiroshi ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Gastrointestinal motility; Intestine; Lubiprostone; Prostaglandin E; Receptors; Small

Indexed keywords

LUBIPROSTONE; PROSTAGLANDIN E RECEPTOR 1;

ANIMAL TISSUE; ARTICLE; ELECTRIC FIELD; INTESTINE MUSCLE; MOUSE; MUSCLE TONE; NONHUMAN; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SPHINCTER; STIMULATION;

EID: 84880650097     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm.2013.19.3.312     Document Type: Article

References (25)

1. Camilleri M, Bharucha AE, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol 2006;290:G942-G947.
2. Cuppoletti J, Malinowska DH, Tewari KP, et al. SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol 2004;287(6 Pt 1):C1173-C1183.
3. Ueno R, Osama H, Habe T, Engelke K, Patchen M. Oral SPI-0211 increases intestinal fluid secretion and chloride concentration without altering serum electrolyte levels [abstract]. Gastroenterology 2004;126(suppl 2):A298.
4. Sun X, Wang X, Wang GD, et al. Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine. Dig Dis Sci 2011;56:330-338.
5. Hussar DA. New drugs: lubiprostone, ranolazine, and anidulafungin. J Am Pharm Assoc 2006;46:411-414.
6. Bassil AK, Borman RA, Jarvie EM, et al. Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Br J Pharmacol 2008;154:126-135.
7. Parentesis GP, Crawford DF, Engelke KJ, Osama H, Ueno R. Effects of lubiprostone, a novel GI chloride channel activator, on isolated smooth muscle [abstract]. Neurogastroenterol Motil 2005;17: 625.
8. Cuthbert AW. Lubiprostone targets prostanoid EP4 receptors in ovine airways. Br J Pharmacol 2011;162:508-520.
9. Kim CD, Goyal RK, Mashimo H. Neuronal NOS provides nitrergic inhibitory neurotransmitter in the mouse lower esophageal sphincter. Am J Physiol 1999;277(2 Pt 1):G280-G284.
10. Grider JR. Reciprocal activity of longitudinal and circular muscle during intestinal peristaltic reflex. Am J Physiol Gastrointest Liver Physiol 2003;284:G768-G775.
11. Botella A, Delvaux M, Fioramonti J, Frexinos J, Bueno L. Stimulatory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in isolated ileal smooth muscle cells. Eur J Pharmacol 1993;237:131-137.
12. Smida SD, Svensson KM. Inhibition of cyclooxygenase-2 and EP1 receptor antagonism reduces human colonic longitudinal muscle contractility in vitro. Prostaglandins Other Lipid Mediat 2009;88:117-121.
13. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 2007;282:11613-11617.
14. Katoh H, Watabe A, Sugimoto Y, Ichikawa A, Negishi M. Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells. Biochim Biophys Acta 1995;1244:41-48.
15. Ding M, Kinoshita Y, Kishi K, et al. Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins 1997;53: 199-216.
16. Morimoto K, Sugimoto Y, Katsuyama M, et al. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 1997;272(3 Pt 1): G681-G687.
17. Northey A, Denis D, Cirino M, Metters KM, Nantel F. Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract. Prostaglandins Other Lipid Mediat 2000;62:145-156.
18. Zhang W, Segura BJ, Lin TR, Hu Y, Mulholland MW. Intercellular calcium waves in cultured enteric glia from neonatal guinea pig. Glia 2003;42:252-262.
19. Zhang W, Sarosi G Jr, Barnhart D, Yule DI, Mulholland MW. Endothelin-activated calcium signaling in enteric glia derived from neonatal guinea pig. Am J Physiol 1997;272(5 Pt 1):G1175-G1185.
20. Bassotti G, Villanacci V, Fisogni S, et al. Enteric glial cells and their role in gastrointestinal motor abnormalities: Introducing the neuro-gliopathies. World J Gastroenterol 2007;13:4035-4041.
21. Bijvelds MJ, Bot AG, Escher JC, De Jonge HR. Activation of intestinal Cl-secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Gastroenterology 2009;137:976-985.
22. O'Brien CE, Anderson PJ, Stowe CD. Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series. Ann Pharmacother 2010;44:577-581.
23. Kawamori T, Kitamura T, Watanabe K, et al. Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development. Carcinogenesis 2005;26:353-357.
24. Kitamura T, Itoh M, Noda T, et al. Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Sci 2003;94:618-621.
25. Chamberlain SM, Rao SS. Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome. Expert Opin Drug Saf 2012;11:841-850.